Headline News about Travere Therapeutics Inc
![](https://cdn.benzinga.com/files/images/story/2023/09/21/image45.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/748438/scientists-examine-cell-make-up-microscope-biotech.jpg)
![](https://www.investors.com/wp-content/uploads/2017/10/Stock-biotechLab-01-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Analyst Ratings for Travere Therapeutics
September 06, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Travere Therapeutics
August 18, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Expert Ratings for Travere Therapeutics
July 18, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for Travere Therapeutics
June 07, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Recap: Travere Therapeutics Q1 Earnings
May 04, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Travere Therapeutics
May 03, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/09/21/gold-image.jpg?width=1200&height=800&fit=crop)
Gold Down Over 1%; FedEx Shares Rise On Earnings Beat
September 21, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/09/21/image34.jpeg?width=1200&height=800&fit=crop)
Nasdaq Down Over 1%; US Initial Jobless Claims Fall More Than Expected
September 21, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/09/21/tvtx.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 21, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/09/21/broadcom_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/Calliditas_CEO_For_BZ.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/740630/scientists-in-a-lab.jpg)
![](https://images.pexels.com/photos/2280549/pexels-photo-2280549.jpeg?auto=compress&cs=tinysrgb&h=750&w=1260)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/17/aapharma_6.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2019/10/stock-drugs-needle-01-adobe.jpg)
![](https://investorplace.com/wp-content/uploads/2021/03/biotech-stocks-2.jpg)
![](https://investorplace.com/wp-content/uploads/2022/04/pte_biotech_1600-1024x576.png)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.